InMed Pharmaceuticals (INM) Operating Expenses (2019 - 2026)
InMed Pharmaceuticals (INM) posted quarterly Operating Expenses of $2.8 million for Q1 2026, up 36.28% year-over-year from $2.1 million in Q1 2025, and up 24.17% quarter-over-quarter from $2.3 million in Q4 2025.
InMed Pharmaceuticals (INM) Operating Expenses (2019 - 2026) Analysis & Trends
InMed Pharmaceuticals' Operating Expenses history runs 8 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 36.28% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $10.4 million (up 9.11% YoY), while the FY2025 annual figure was $9.7 million, up 3.83% from the prior year.
- Operating Expenses for Q1 2026 stood at $2.8 million, up from $2.3 million in the prior quarter.
- The five-year high for Operating Expenses was $6.8 million in Q2 2022, with the low at $2.0 million in Q4 2023.
- The 5-year median for Operating Expenses is $2.3 million (2022), against an average of $2.8 million.
- The sharpest annual moves came in 2022 and 2023: Operating Expenses soared 104.75% in 2022, then plunged 69.64% in 2023.
- InMed Pharmaceuticals' Operating Expenses stood at $2.3 million in 2022, then dropped by 16.03% to $2.0 million in 2023, then surged by 37.88% to $2.7 million in 2024, then retreated by 15.77% to $2.3 million in 2025, then gained by 24.17% to $2.8 million in 2026.
- Business Quant data shows INM's Operating Expenses at $2.8 million in Q1 2026, $2.3 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | InMed Pharmaceuticals | 6.52 Mn | 1.28 Mn | - | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | 2.29 Mn |
| Sep 30, 2025 | 2.22 Mn |
| Jun 30, 2025 | 3.04 Mn |
| Mar 31, 2025 | 2.08 Mn |
| Dec 31, 2024 | 2.71 Mn |
| Sep 30, 2024 | 2.23 Mn |
| Jun 30, 2024 | 2.50 Mn |
| Mar 31, 2024 | 2.13 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | 2.69 Mn |
| Jun 30, 2023 | 2.06 Mn |
| Mar 31, 2023 | 2.34 Mn |
| Dec 31, 2022 | 2.35 Mn |
| Sep 30, 2022 | 3.08 Mn |
| Jun 30, 2022 | 6.77 Mn |
| Mar 31, 2022 | 3.72 Mn |
| Dec 31, 2021 | 4.42 Mn |
| Sep 30, 2021 | 2.89 Mn |
| Jun 30, 2021 | 3.31 Mn |